Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James W Hart

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 11, 2022
Multisystem inflammatory syndrome in childrenNeil Chanchlani, Emily Chesshyre, James W Hart
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 9, 2021
Neil Chanchlani, Simon C Parke, James W Hart
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 5, 2021
Langerhans cell histiocytosis in a 5-month-old babyNeil Chanchlani, Simon C Parke, James W Hart
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
The emerging role of gemcitabine in conditioning regimens for hematopoietic stem cell transplantationEmily Wang, Alison Gulbis, James W Hart, et al.
Therapeutic Advances in Hematology|October 2, 2013
Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinionJames W Hart, Lisa H Shiue, Elizabeth J Shpall, et al.
Archives of Disease in Childhood. Education and Practice Edition|December 17, 2020
Adolescent with abdominal pain poorly responsive to analgesiaNeil Chanchlani, Philip Jarvis, James W Hart, et al.
Archives of Disease in Childhood|May 20, 2020
Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy studyGareth J Walker, Neil Chanchlani, Amanda Thomas, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|July 11, 2022
Multisystem inflammatory syndrome in childrenNeil Chanchlani, Emily Chesshyre, James W Hart
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|March 9, 2021
Neil Chanchlani, Simon C Parke, James W Hart
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|January 5, 2021
Langerhans cell histiocytosis in a 5-month-old babyNeil Chanchlani, Simon C Parke, James W Hart
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 13, 2014
The emerging role of gemcitabine in conditioning regimens for hematopoietic stem cell transplantationEmily Wang, Alison Gulbis, James W Hart, et al.
Therapeutic Advances in Hematology|October 2, 2013
Extracorporeal photopheresis in the treatment of graft-versus-host disease: evidence and opinionJames W Hart, Lisa H Shiue, Elizabeth J Shpall, et al.
Archives of Disease in Childhood. Education and Practice Edition|December 17, 2020
Adolescent with abdominal pain poorly responsive to analgesiaNeil Chanchlani, Philip Jarvis, James W Hart, et al.
Archives of Disease in Childhood|May 20, 2020
Primary care faecal calprotectin testing in children with suspected inflammatory bowel disease: a diagnostic accuracy studyGareth J Walker, Neil Chanchlani, Amanda Thomas, et al.
Alimentary Pharmacology & Therapeutics|August 30, 2022
Implications for sequencing of biologic therapy and choice of second anti-TNF in patients with inflammatory bowel disease: results from the IMmunogenicity to Second Anti-TNF therapy (IMSAT) therapeutic drug monitoring studyNeil Chanchlani, Simeng Lin, Marcus K Auth, et al.
Pageof 1